Skip to content
Home/Companies/Pharma/Immedica

Immedica

Pharma·Sweden·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Immedica?

Immedica is a Swedish Pharma company, currently owned by Impilo since 2018.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Impilo
Investor
Impilo
Impilo Investment Pool 1 · 2018 · Buyout

Key facts

HQSweden
SectorPharma
StatusActive

More from Impilo Investment Pool 1

Other portfolio companies in the same fund.

Euro Accident
Active
FinancialsSweden· 2019
Humana
Active
HealthcareSweden· 2019
TFP Fertility
Exited 2024
HealthcareUK· 2019
to Benefit Street Partners
Cavidi
Exited 2020
MedTechSweden· 2018
to Original founders
Ferrosan Medical Devices
Exited 2024
MedTechDenmark· 2017
to Kirk Kapital, Lundbeckfonden and ATP
NutraQ
Exited 2021
ConsumerNorway· 2017
to Orkla

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Immedica?

Immedica is currently owned by Impilo, through Impilo Investment Pool 1, since 2018.

When did Impilo acquire Immedica?

Impilo acquired Immedica in 2018.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue